-
5 楼 发表于2011-03-07 01:09:00举报|引用
-
返回顶部 | 快捷回复
Validation Study of Oxford Classification of IgA Nephropathy in a Chinese Cohort.
Shaoshan
Liang, Caihong Zeng, Sharon Phillips, Yu Shyr, Stephan Troyanov,
Zhi-Hong Liu, Agnes B Fogo. Nanjing Research Institute of Nephrology,
Jiangsu, China; Vanderbilt Unversity, Nashville, TN; H244;pital du
Sacré-Coeur de Montréal, University of Montreal, QC, Canada
Background:
The Oxford Classification of IgA Nephropathy (IgAN) identified four
renal biopsy lesions of prognostic significance, namely mesangial
hypercellularity, segmental glomerulosclerosis/adhesion, endocapillary
proliferation and significant tubular atrophy/interstitial fibrosis. We
now sought to validate whether these results were applicable in a
Chinese cohort of patients.
Design: 213 adult Chinese patients
from a single center, Nanjing Research Institute of Nephrology were
studied. Inclusion criteria were as in the original Oxford cohort, with
eGFR ≥ 30 ml/min and minimum of one year follow up, excluding patients
with rapid progression in less than a year, or with no or minimal
proteinuria, diabetes or other glomerulonephritis. Renal biopsies
included at least 10 glomeruli.
Results: Patients were on
average age 34 years (range 18-65), 46.5% female. MAP was higher than in
the Oxford cohort (102 ± 22 mm Hg) at time of biopsy. RAS blockade at
time of biopsy, and during followup were similar to the Oxford cohort.
Follow up was on average 81 months (range 30-157 months). 21.1% received
immunosuppression, 14.6% prednisone and 7.5% cyclophosphamide, all
slightly less than the Oxford cohort. Rate of renal function decline was
-2.2 ± 4.2 ml/min per 1.73 m2 per year, with 20.2% reaching
50% decline in renal function and 14.1% reaching ESRD, all similar to
the original Oxford cohort. On average, 22.7 ± 8.8 (range 8-61)
glomeruli were available. All Oxford classification variables were
scored independently by two pathologists. Global sclerosis/advanced
segmental sclerosis was present in 19.8% of glomeruli. Segmental
sclerosis was present in 85% of biopsies. Significant mesangial
hypercellularity, endocapillary proliferation, segmental sclerosis were
present in, on average, 65, 22 and 85% of biopsies. Significant
tubulointerstitial fibrosis (T1 or T2), >25%, was present in 33%.
Tubulointerstitial fibrosis correlated with proteinuria and loss of eGFR
over time, and endocapillary proliferation (E1) correlated with
proteinuria over followup. Mesangial proliferation (M1) and segmental
sclerosis/adhesion (S1) did not predict changes in eGFR or proteinuria
in this cohort.
Conclusions: In conclusion, application of the
Oxford IgAN classification to Chinese patients shows similar trends for
prediction of clinical outcome in some, but not all variables, as the
previous data set.
Validation Study of Oxford Classification of IgA Nephropathy in a Chinese Cohort.
Shaoshan
Liang, Caihong Zeng, Sharon Phillips, Yu Shyr, Stephan Troyanov,
Zhi-Hong Liu, Agnes B Fogo. Nanjing Research Institute of Nephrology,
Jiangsu, China; Vanderbilt Unversity, Nashville, TN; H244;pital du
Sacré-Coeur de Montréal, University of Montreal, QC, Canada
Background:
The Oxford Classification of IgA Nephropathy (IgAN) identified four
renal biopsy lesions of prognostic significance, namely mesangial
hypercellularity, segmental glomerulosclerosis/adhesion, endocapillary
proliferation and significant tubular atrophy/interstitial fibrosis. We
now sought to validate whether these results were applicable in a
Chinese cohort of patients.
Design: 213 adult Chinese patients
from a single center, Nanjing Research Institute of Nephrology were
studied. Inclusion criteria were as in the original Oxford cohort, with
eGFR ≥ 30 ml/min and minimum of one year follow up, excluding patients
with rapid progression in less than a year, or with no or minimal
proteinuria, diabetes or other glomerulonephritis. Renal biopsies
included at least 10 glomeruli.
Results: Patients were on
average age 34 years (range 18-65), 46.5% female. MAP was higher than in
the Oxford cohort (102 ± 22 mm Hg) at time of biopsy. RAS blockade at
time of biopsy, and during followup were similar to the Oxford cohort.
Follow up was on average 81 months (range 30-157 months). 21.1% received
immunosuppression, 14.6% prednisone and 7.5% cyclophosphamide, all
slightly less than the Oxford cohort. Rate of renal function decline was
-2.2 ± 4.2 ml/min per 1.73 m2 per year, with 20.2% reaching
50% decline in renal function and 14.1% reaching ESRD, all similar to
the original Oxford cohort. On average, 22.7 ± 8.8 (range 8-61)
glomeruli were available. All Oxford classification variables were
scored independently by two pathologists. Global sclerosis/advanced
segmental sclerosis was present in 19.8% of glomeruli. Segmental
sclerosis was present in 85% of biopsies. Significant mesangial
hypercellularity, endocapillary proliferation, segmental sclerosis were
present in, on average, 65, 22 and 85% of biopsies. Significant
tubulointerstitial fibrosis (T1 or T2), >25%, was present in 33%.
Tubulointerstitial fibrosis correlated with proteinuria and loss of eGFR
over time, and endocapillary proliferation (E1) correlated with
proteinuria over followup. Mesangial proliferation (M1) and segmental
sclerosis/adhesion (S1) did not predict changes in eGFR or proteinuria
in this cohort.
Conclusions: In conclusion, application of the
Oxford IgAN classification to Chinese patients shows similar trends for
prediction of clinical outcome in some, but not all variables, as the
previous data set.
- 0